{"rewrite":{"id":"r_0be4d1fd92ee0bceffc43a70","clusterId":"c_880b27ef4e9c2e8d65d6f707","slug":"mitsui-and-qsimulate-partner-with-chugai-to-build-out-qido-for-pharma-research","model":"deepseek-v4-1-flash","headline":"Mitsui and QSimulate Partner with Chugai to Build Out QIDO for Pharma Research","summary":"Mitsui \u0026 Co. and QSimulate said on November 12 that they will work with Chugai Pharmaceutical to develop pharmaceutical research functions for QIDO, their quantum-classical hybrid computational chemistry platform. A theme proposed by Chugai, with QSimulate as co-proposer and Mitsui as collaborator, was adopted for the JHPC-quantum test user program, where QIDO will run on the quantum-HPC integration platform.","whyItMatters":"The deal turns QIDO's roadmap toward functions shaped by an actual pharma user's evaluation, with the JHPC-quantum adoption giving the three companies a staged test of a classical, GPU, and quantum workflow against active pharmaceutical ingredient synthesis.","webCardHtml":"\u003cp\u003eThe adopted theme targets active pharmaceutical ingredient synthesis, where the companies plan to verify a workflow that combines classical computation, GPU computation, and quantum computation. They will assess technical feasibility, scientific validity, reproducibility, operability, and applicability to pharmaceutical research in stages.\u003c/p\u003e\u003cp\u003eFunctions developed under the collaboration are planned for release as general-purpose QIDO product functions, available to pharmaceutical and chemical companies beyond Chugai. The work centers on reaction mechanism analysis and reaction pathway search for the complex molecules and reactions handled in drug discovery.\u003c/p\u003e","blueskyPost":"QIDO's pharma build-out runs through Chugai's own adopted theme, not a Mitsui-led pitch. The drugmaker sets what QIDO must do on the quantum-HPC platform.","twitterPost":"Chugai's theme was the one adopted for JHPC-quantum. QIDO's pharma functions follow the drugmaker's spec, not the vendors'.","threadsPost":"QIDO's pharma features get built against Chugai's adopted JHPC-quantum theme, with QSimulate as co-proposer and Mitsui as collaborator. The drugmaker defines the research problem, and the platform vendors work to it.","newsletterBlurb":"Mitsui \u0026 Co. and QSimulate are working with Chugai Pharmaceutical to develop pharmaceutical research functions for QIDO, their quantum-classical hybrid computational chemistry platform. A theme with Chugai as representative proposer and QSimulate as co-proposer was adopted for the JHPC-quantum test user program. QIDO will run on the quantum-HPC integration platform, with staged verification of a classical, GPU, and quantum workflow for active pharmaceutical ingredient synthesis.","attributionJson":"[{\"source\":\"ASCII.jp\",\"url\":\"https://ascii.jp/elem/000/004/451/4451070/?rss\",\"title\":\"Mitsui \\u0026 Co. and QSimulate, in collaboration with Chugai Pharmaceutical, to enhance QIDO's pharmaceutical research functions; participating in adopted JHPC-quantum theme\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":5485,"outputTokens":815,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1794472167,"createdAt":"2026-11-12T08:24:15.000Z","publishedAt":"2026-11-12T08:28:22.000Z","updatedAt":"2026-11-12T08:28:22.000Z"},"cluster":{"id":"c_880b27ef4e9c2e8d65d6f707","canonicalTitle":"三井物産とQSimulate、中外製薬との協創で「QIDO」の製薬研究向け機能を高度化、JHPC-quantum採択テーマに参画","representativeArticleId":"a_567130537161ed5424d24d6c","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[\"QIDO\"],\"studios\":[\"Mitsui \\u0026 Co.\",\"QSimulate\",\"Chugai Pharmaceutical\"],\"people\":[],\"type\":\"business\",\"domain\":\"industry\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-11-12T06:00:00.000Z","lastSeenAt":"2026-11-12T06:00:00.000Z","updatedAt":"2026-11-12T08:28:22.000Z"},"attribution":[{"source":"ASCII.jp","url":"https://ascii.jp/elem/000/004/451/4451070/?rss","title":"三井物産とQSimulate、中外製薬との協創で「QIDO」の製薬研究向け機能を高度化、JHPC-quantum採択テーマに参画"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":["QIDO"],"studios":["Mitsui \u0026 Co.","QSimulate","Chugai Pharmaceutical"],"people":[],"type":"business","domain":"industry","is_roundup":false},"keyFacts":["Mitsui \u0026 Co. and QSimulate announced on November 12, 2026, a collaboration with Chugai Pharmaceutical on QIDO, a quantum-classical hybrid computational chemistry platform.","A theme with Chugai Pharmaceutical as representative proposer and QSimulate as co-proposer was adopted for the JHPC-quantum test user program, with Mitsui \u0026 Co. as collaborator.","QIDO will be implemented on the quantum-HPC integration platform, and verification will target complex chemical reactions in active pharmaceutical ingredient synthesis processes.","The companies plan to evaluate technical feasibility, scientific validity, reproducibility, operability, and applicability to pharmaceutical research in stages.","Functions developed under the collaboration are planned for release as general-purpose QIDO product functions for pharmaceutical and chemical companies."],"pageLinks":{"healthSlugs":["qido","mitsui-co","qsimulate","chugai-pharmaceutical"],"storySlugs":[],"entities":[{"slug":"qido","supported":0,"disputed":0,"contradicted":0,"unverified":6,"overall":"unverified","story_count":1,"has_dossier":false},{"slug":"mitsui-co","supported":0,"disputed":0,"contradicted":0,"unverified":1,"overall":"unverified","story_count":1,"has_dossier":false},{"slug":"qsimulate","supported":0,"disputed":0,"contradicted":0,"unverified":1,"overall":"unverified","story_count":1,"has_dossier":false},{"slug":"chugai-pharmaceutical","supported":0,"disputed":0,"contradicted":0,"unverified":1,"overall":"unverified","story_count":1,"has_dossier":false}],"stories":[],"entitiesOk":true,"storiesOk":true}}